SMNIN Shemen Industries Ltd.

SOHM, Inc. Files All Quarterly and Annual Financials to Move Current with OTC

SOHM, Inc. Files All Quarterly and Annual Financials to Move Current with OTC

Chino Hills, CA, July 26, 2018 (GLOBE NEWSWIRE) -- SOHM, Inc. (PINKSHEETS: SHMN) a globally-known generic pharmaceutical manufacturer -- SOHM, Inc.’s Annual Financial for year ending 2016, 2017 and first qtr. which is ended on March 31, 2018: We are glad that we have now released all financials. Company is working with its counsel to work with OTC to satisfy its compliance to move to Current, and in appropriate time when we come to know the progress, the company will inform its shareholders with updates.

About SOHM, Inc.

SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a global presence and marketing plan that assure continuous growth. SOHM manufacturing and marketing target the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing in India as well as strategic alliance with US manufacturing facilities. Although SOHM’s generic pharmaceuticals are exported globally and was introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia.



To know more about SOHM, Inc., visit 

Safe Harbor Statement:

This news release contains “forward-looking statements”, which are statements that are not purely historical and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on for the most recent fiscal year, our quarterly reports uploaded from time-to-time on OTCMarkets.com.



For more information, please contact:
SOHM, Inc.
714-522-6700
EN
26/07/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Shemen Industries Ltd.

 PRESS RELEASE

NOTICE TO DISREGARD - SOHM, Inc.

NOTICE TO DISREGARD - SOHM, Inc. Chino Hills, CA, Aug. 09, 2018 (GLOBE NEWSWIRE) -- We are advised by SOHM, Inc. (PINKSHEETS: SHMN) that journalists and other readers should disregard the news release, "SOHM, Inc. Subsidiary Daiichi Sankyo Group Files Its Acute Myeloid Leukemia (AML) Treatment Quizartinib in the US; the FDA Awarded Breakthrough Status for The Drug," issued Thursday, August 9, 2018, over GlobeNewswire. 

 PRESS RELEASE

SOHM, Inc. Announces Potential Purchase Orders for a Range of Pharmace...

SOHM, Inc. Announces Potential Purchase Orders for a Range of Pharmaceutical Products Chino Hills, CA, Aug. 02, 2018 (GLOBE NEWSWIRE) -- SOHM, Inc. (PINKSHEETS: SHMN), a globally-known generic pharmaceutical manufacturer, is negotiating multiple purchase orders for a range of Pharmaceutical products. This potential purchase order comes from current customers that have executed purchase orders with SOHM in the past. New potential customers are inquiring about our Pharmaceutical products. A spokesperson for SOHM, Inc., said, “SOHM is very pleased to have received these potential orders f...

 PRESS RELEASE

SOHM, Inc. Fully Paid Nevada Secretary of State Fee and is Seeking to ...

SOHM, Inc. Fully Paid Nevada Secretary of State Fee and is Seeking to be OTC Current  Chino Hills, CA, Aug. 01, 2018 (GLOBE NEWSWIRE) -- SOHM, Inc. (PINKSHEETS: SHMN) a globally-known generic pharmaceutical manufacturer, is now active with the Nevada Secretary of State and is rigorously continuing to file all documents needed. All fees with the Nevada State have been submitted.  The Company is working with its counsel to work with OTC to satisfy its compliance to move to Current, and in the appropriate time when we come to know the progress, the Company will inform its shareholders wit...

 PRESS RELEASE

SOHM, Inc. Files All Quarterly and Annual Financials to Move Current w...

SOHM, Inc. Files All Quarterly and Annual Financials to Move Current with OTC Chino Hills, CA, July 26, 2018 (GLOBE NEWSWIRE) -- SOHM, Inc. (PINKSHEETS: SHMN) a globally-known generic pharmaceutical manufacturer -- SOHM, Inc.’s Annual Financial for year ending 2016, 2017 and first qtr. which is ended on March 31, 2018: We are glad that we have now released all financials. Company is working with its counsel to work with OTC to satisfy its compliance to move to Current, and in appropriate time when we come to know the progress, the company will inform its shareholders with updates. ...

 PRESS RELEASE

SOHM, Inc. Announces No Reverse Split and No Increase of Authorize Sha...

SOHM, Inc. Announces No Reverse Split and No Increase of Authorize Shares Chino Hills, CA, July 24, 2018 (GLOBE NEWSWIRE) -- SOHM, Inc. (PINKSHEETS: SHMN), a globally-known generic pharmaceutical manufacturer, would like to clarify certain information and facts as following. Our current Share Structure is as follows: Outstanding Shares 1,547,798,629 as of June 13, 2018; Shares in the Float 1,247,784,441 as of June 13, 2018. We have received requests from some shareholders to clarify about some investors sharing falsely made claims about the company and its operation on various company ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch